Akdital Group’s consolidated net profit reached 127 million dirhams (MDH) in the first half of 2024, marking a significant 70% increase compared to the same period in 2023. According to a company statement, the group’s net income stood at 113 MDH.
The group’s revenue climbed to 1.249 billion dirhams by the end of June 2024, a 51% jump from the 828 MDH recorded by June 2023. This strong performance is attributed to the consolidation of its established entities and the success of facilities opened in 2022 and 2023.
Notably, the oncology segment’s contribution to total revenue rose from 29% in the first half of 2023 to 32% in the same period of 2024.
In addition, the group’s EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization) reached 334 MDH, up by 56%, driven by operational efficiency efforts and stringent cost management, as highlighted in the statement.
